TEST KIT

Date

2014 – 2016

Description

OraQuick Ebola rapid antigen oral swab combined test kit components – a test device and developer solution vial.

The OraQuick test for the Ebola virus was developed in the United States and sent to clinics and treatment centers in Liberia, Sierra Leone, and Guinea under an emergency use authorization during the 2014 – 2016 Ebola response in West Africa.

Source

United States Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), OraSure Technologies Inc.